A detailed history of Bristol Gate Capital Partners Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Bristol Gate Capital Partners Inc. holds 172,330 shares of MCK stock, worth $108 Million. This represents 3.91% of its overall portfolio holdings.

Number of Shares
172,330
Previous 173,952 0.93%
Holding current value
$108 Million
Previous $102 Million 16.17%
% of portfolio
3.91%
Previous 5.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$479.06 - $630.38 $777,035 - $1.02 Million
-1,622 Reduced 0.93%
172,330 $85.2 Million
Q2 2024

Aug 12, 2024

SELL
$518.81 - $607.81 $3.98 Million - $4.67 Million
-7,681 Reduced 4.23%
173,952 $102 Million
Q1 2024

May 10, 2024

BUY
$473.42 - $539.26 $86 Million - $97.9 Million
181,633 New
181,633 $97.5 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.8B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bristol Gate Capital Partners Inc. Portfolio

Follow Bristol Gate Capital Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristol Gate Capital Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bristol Gate Capital Partners Inc. with notifications on news.